Scientists at Johns Hopkins University are pioneering a new approach to treating dangerous heart arrhythmias by creating virtual replicas of patients’ hearts. These “digital twins” allow doctors to simulate treatment options and optimize procedures before intervening on the real organ.

Digital Twins: A New Era in Cardiology

The research, published in the New England Journal of Medicine on Wednesday, represents a small but significant first step. The Food and Drug Administration authorized the use of this digital twin technology to guide treatment for 10 patients. Larger studies are planned to further validate the findings.

How Digital Twins Work

The process begins with advanced MRI scans and other patient data, which are used to develop a highly detailed, interactive model of the heart. Natalia Trayanova, a biomedical engineer at Johns Hopkins, explains, “We treat the twin before we treat the patient. Did it work? And if it did, are there new things that arise” that will require more or different care?

Targeting Ventricular Tachycardia

The study focused on ventricular tachycardia, a life-threatening arrhythmia caused by electrical short-circuits in the heart’s ventricles. This condition is a major contributor to sudden cardiac arrest, responsible for approximately 300,000 U.S. deaths annually.

Current treatment typically involves catheter ablation, a trial-and-error process where doctors burn misfiring tissue. The digital twin technology aims to pinpoint the exact areas causing the arrhythmia, reducing the need for extensive and potentially damaging ablation.

Simulating and Optimizing Ablation

The digital twins visually represent the heart’s electrical activity, with colors indicating the flow of electrical waves. Trayanova compares the problematic electrical patterns to a “hurricane” swirling around damaged tissue. By virtually ablating the dysfunctional region, doctors can predict the outcome and refine their approach.

Promising Early Results

In the initial study, cardiologists used the digital twin-generated targets to guide ablation procedures in 10 patients. Dr. Jonathan Chrispin, the study’s lead author, reported that over a year later, eight patients showed no signs of arrhythmia, while the remaining two experienced only brief episodes during recovery. This represents a significant improvement over the typical 60% success rate of traditional ablation.

Furthermore, eight out of ten patients were able to discontinue their anti-arrhythmia medication. The team hopes to expand the study to include a larger patient population and explore the use of digital twins for other heart conditions, such as atrial fibrillation.

Dr. Jeffrey Goldberger, a heart specialist at the University of Miami who was not involved in the study, praised the findings, stating, “This is what we envisioned.”